Base promoted synthesis of novel indole-dithiocarbamate compounds as potential anti-inflammatory therapeutic agents for treatment of acute lung injury.
Base promoted synthesis of novel indole-dithiocarbamate compounds as potential anti-inflammatory therapeutic agents for treatment of acute lung injury.
复制标题
DOI:
10.1016/j.ejmech.2019.03.022
复制
发表时间:
2019-06
影响因子:
6.7
通讯作者:
Zengqiang Song;Yan Zhou;Wenxin Zhang;L. Zhan;Yuanzu Yu;Yuehui Chen;W. Jia;Zhiguo Liu;Jianchang Qian;Yali Zhang;Chenglong Li;G. Liang
中科院分区:
文献类型:
--
作者:
Zengqiang Song;Yan Zhou;Wenxin Zhang;L. Zhan;Yuanzu Yu;Yuehui Chen;W. Jia;Zhiguo Liu;Jianchang Qian;Yali Zhang;Chenglong Li;G. Liang
An efficient protocol for highly chemoselective introduction of dithiocarbamate groups to nitrogen position of indoles with bis(dialkylaminethiocarbonyl)disulfides was achieved by employingt-BuOK as a promoter. Based on this methodology, twenty nine novel indole-dithiocarbamate compounds were prepared in moderate to excellent yields at room temperature. All compounds were evaluated for their anti-inflammatory activity. Most of the compounds exhibited high potency on inhibiting the releasing of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6). Four of them were found to suppressin vitro cytokine production in a dose-dependent manner with IC50values in the nanomolar range. Additionally, 3-methyl-1H-indol-1-yl dimethylcarbamodithioate(3o)effectively ameliorated histopathological changes of lung tissues and attenuated lipopolysaccharides (LPS)-induced acute lung injury (ALI)in vivo. These data suggest that the new indole-dithiocarbamate derivatives could be particularly useful for further pharmaceutical development for the treatment of ALI.